Trial intelligence / Profile preview

Naproxen and Lidocaine Gel Combination in Traumatic Rib Fractures

NCT07706036Completed

Sponsor
Ankara City Hospital
Start
Jan 2024
Primary completion
Jul 2024
Countries
1
01

Overview

Randomised trial of naproxen and lidocaine 10% oropharyngeal spray in rib fracture (2 arms), sponsored by Ankara City Hospital. Primary endpoint: Numerical Rating Scale at 60 months. Started Jan 2024; status: completed.

02

Drugs

naproxenlidocaine 10% oropharyngeal spray
03

Conditions

rib fracture

Beyond the preview

Go deeper on NCT07706036.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07706036.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call